207 publications
Name | Date | Type | Actions |
---|---|---|---|
In 2023 Vetoquinol celebrates its 90th anniversary. - 90 years The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health. |
Press releases communication | ||
Annual sales 2022 Total group Sales: €540 million (up 3.6% as reported) |
Public releases | ||
CALENDAR 2023 Stock exchange market – non authorized periods The "negative windows" are the abstention periods during which it is forbidden to trade in the Company's securities. |
Financial Documents | ||
2023 calendar of financial communication Vetoquinol published its calendar of financial communication for 2023. |
Agenda | ||
First nine months 2022 sales: €405M In line with year-end outlook |
Public releases | ||
2022 HALF YEAR RESULTS Additional information on the Group’s strategy Following the conference call organised on 15 September 2022 to present its half-year results, Vetoquinol would like to provide some additional information on the strategy implemented and its outlook. |
Public releases , Half Year Report | ||
2022 HALF YEAR RESULTS Sales: €271m (up 6.0% as reported) |
Public releases | ||
H1 2022 Sales H1 2022 Sales: €271m, up 6.1% |
Public releases | ||
Availability of the 2021 universal registration document Vetoquinol informs that it has filed its 2021 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 22th, 2022. |
Public releases | ||
Q1 2022 SALES: €135M Q1 2022 SALES: €135M |
Public releases |